Clinical trial / 2009
Bariatric surgery was associated with reduced cancer incidence in obese women, but not in obese men, over a median 10.9-year follow-up.
The Swedish Obese Subjects study followed 2,010 obese patients undergoing bariatric surgery and 2,037 matched controls receiving conventional treatment for a median of 10.9 years. Surgery resulted in a sustained mean weight reduction of 19.9 kg over 10 years compared to a 1.3 kg gain in controls. First-time cancers were significantly lower in the surgery group (117 cases) compared to controls (169 cases; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The reduction was observed in women (HR 0.58, 95% CI 0.44-0.77, p=0.0001), but not in men (HR 0.97, 95% CI 0.62-1.52, p=0.90; sex-treatment interaction p=0.054).
- Study type
- Prospective, controlled intervention trial
- Who was studied
- 4,047 obese patients (2,010 undergoing bariatric surgery and 2,037 matched controls)
- What was measured
- First-time cancer incidence and sustained weight change over 10 years
THE PAPER
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial.
Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P, Karason K, Karlsson J, Larsson B, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Carlsson LM, Swedish Obese Subjects Study. Lancet Oncol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.